ALCON INC ALC

Healthcare SIC 3851 - Ophthalmic Goods NYSE

Last close —

Market cap —

52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—

P/E—

P/FCF—

EV/EBITDA—

Dividend yield—

Diluted EPS—

Annual financial statements

Income statement

Fiscal year	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	$10.40B	$9.91B	$9.46B	$8.72B	$8.29B	$6.83B	$7.51B	$7.15B	$6.79B	—
Operating income	$1.36B	$1.41B	$1.04B	$672.0M	$580.0M	-$482.0M	-$187.0M	-$248.0M	-$77.0M	—
Net income	$980.0M	$1.02B	$974.0M	$335.0M	$376.0M	-$531.0M	-$656.0M	-$227.0M	$256.0M	—

Balance sheet

Fiscal year	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	$31.55B	$30.35B	$29.61B	$29.16B	$28.00B	$27.60B	$27.66B	$27.06B	—	—
Total equity	$22.04B	$21.55B	$20.62B	$19.68B	$19.26B	$18.82B	$19.30B	$22.64B	$23.03B	$23.01B

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001167379-26-000014.

Others in SIC 3851

Ticker	Company	Market cap	P/E	Revenue growth
COO	COOPER COMPANIES, INC.	$13.57B	37.2x	5.1%
BLCO	Bausch & Lomb Corp	$6.44B	—	6.5%
WRBY	Warby Parker Inc.	$3.02B	2,435.0x	13.0%
EYE	National Vision Holdings, Inc.	$1.32B	45.2x	9.0%
STAA	STAAR SURGICAL CO	$1.18B	—	-23.7%
RXST	RxSight, Inc.	$265.2M	—	-3.9%
LUCYW	Innovative Eyewear Inc	$275.5K	—	62.6%